LIVN · XBRL financial data

LivaNova financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (LIVN's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue from contracts with customers	286	310*	295	319	318	322*	317	353	358	361*	362	391
Cost of goods and services sold	84	120*	88	100	93	102*	96	114	113	121*	119	117
Gross profit	202	190*	207	219	225	219*	221	239	245	240*	244	274
Research and development	47	46*	46	45	49	43*	38	47	49	52*	59	54
Selling, general and administrative	135	133*	130	129	132	136*	134	138	139	143*	144	158
Other operating income (expense)	(16)	(9)*	(16)	(5)	(9)	(3)*	(1)	0	(4)	(2)*	(0)	(12)
Operating income (loss)	4	(88)*	16	40	36	37*	49	54	54	43*	41	49
Interest income	—	year only	—	—	7	9*	6	4	4	4*	4	4
Interest expense	15	16*	16	16	16	16*	15	12	11	11*	8	7
Other income (expense)	0	1*	(0)	0	0	1*	(0)	0	0	0*	0	0
Income tax expense (benefit)	5	(111)*	8	5	12	1*	12	6	7	(3)*	4	(90)
Net income (loss)	(7)	16*	(42)	16	33	56*	(327)	27	27	31*	22	109
Earnings per share, basic USD per share	(0.14)	0.30*	(0.78)	0.30	0.61	1.03*	(6.01)	0.50	0.49	0.57*	0.41	1.98
Earnings per share, diluted USD per share	(0.14)	0.30*	(0.78)	0.30	0.60	1.01*	(6.01)	0.50	0.49	0.57*	0.40	1.93
Weighted average shares, basic millions of shares	54	54*	54	54	54	54*	54	55	55	55*	55	55
Weighted average shares, diluted millions of shares	54	55*	54	55	55	55*	54	55	55	54*	56	56

Fiscal quarters (LIVN's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	234	267	309	329	346	429	738	594	646	636	540	517
Accounts receivable	190	215	209	201	197	193	202	220	212	216	229	231
Inventory	162	148	153	155	162	148	154	165	168	165	166	173
Prepaid and other current assets	44	27	39	36	43	32	47	54	44	37	38	62
Total current assets	954	988	1,040	1,047	1,093	1,127	1,171	1,066	1,097	1,102	1,014	1,025
Property and equipment, net	149	154	152	158	169	170	178	195	219	243	255	273
Right-of-use asset	32	51	50	50	52	47	48	51	51	56	55	57
Goodwill	767	783	772	766	782	750	762	793	791	793	786	779
Total assets	2,329	2,430	2,460	2,453	2,522	2,506	2,559	2,507	2,558	2,606	2,516	2,641
Accounts payable	63	81	76	81	78	70	88	87	88	97	99	103
Accrued liabilities	90	107	94	98	105	118	108	103	92	95	103	104
Current portion of long-term debt	18	17	19	19	21	77	79	82	85	31	0	0
Total current liabilities	295	335	328	303	324	392	742	827	828	808	762	707
Long-term debt	568	569	605	605	604	550	549	348	349	345	285	290
Lease liability, non-current	25	45	44	44	44	40	40	43	43	48	47	50
Total liabilities	1,104	1,152	1,238	1,211	1,212	1,186	1,524	1,384	1,400	1,406	1,305	1,316
Accumulated deficit	(983)	(966)	(1,008)	(992)	(959)	(903)	(1,231)	(1,203)	(1,177)	(1,146)	(1,123)	(1,015)
Total stockholders' equity	1,225	1,278	1,222	1,243	1,310	1,320	1,034	1,123	1,157	1,200	1,211	1,325
Total liabilities and equity	2,329	2,430	2,460	2,453	2,522	2,506	2,559	2,507	2,558	2,606	2,516	2,641
Common shares outstanding (cover page) millions of shares	54	54	54	54	54	54	55	55	55	55	55	55

Fiscal quarters (LIVN's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	(7)	16*	(42)	16	33	56*	(327)	27	27	31*	22	109
Stock-based compensation	12*	8*	10	8*	9*	7*	8	9*	10*	9*	8	17*
Net cash from operating activities	18*	54*	10	43*	51*	79*	24	63*	85*	82*	15	67*
Purchases of property and equipment	9*	13*	6	12*	18*	10*	11	15*	23*	32*	14	32*
Net cash from investing activities	(10)*	(12)*	(6)	(13)*	(19)*	(11)*	(11)	(9)*	(23)*	(30)*	(15)	(32)*
Proceeds from issuing common stock	—	year only	—	—	—	—	—	—	—	—	—	—
Proceeds from long-term debt	0*	0*	336	0*	0*	0*	0	0*	0*	0*	—	—
Repayments of long-term debt	4*	6*	234	4*	4*	4*	4	206*	7*	64*	96	0*
Net cash from financing activities	(4)*	(5)*	37	(12)*	(3)*	(3)*	(4)	(209)*	(9)*	(63)*	(94)	(56)*
Net change in cash	(2)*	45*	38	17*	33*	57*	15	(145)*	52*	(11)*	(96)	(23)*

SIC 3845 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3845 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
LivaNova	517	391	67*	55.1M	—	Q2 FY26 10-QJun 30, 2026
Envista Holdings	1,126	731	119*	160.6M	—	Q2 FY26 10-QJul 3, 2026
Teleflex	300	570	not reported	42.4M	—	Q2 FY26 10-QJun 30, 2026
Haemonetics	223	339	52	45.5M	—	Q1 FY27 10-QJun 27, 2026
Dentsply Sirona	239	898	99*	199.4M	—	Q2 FY26 10-QJun 30, 2026
PROCEPT BioRobotics	228	94	(19)*	57.3M	11.8 quarters	Q2 FY26 10-QJun 30, 2026
Icu Medical	298	552	80*	25.0M	—	Q2 FY26 10-QJun 30, 2026
Enovis	13	583	75*	57.7M	—	Q2 FY26 10-QJul 3, 2026
Ufp Technologies	9	174	16*	7.7M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.